Healthcare Innovation CSR News

[WEBINAR] Reimagining Community Health Systems: Join SAP, Medtronic, and Leading Nonprofits in Community Health (Thurs, 10/15, 12 - 1 EDT)

Addressing our Health Crisis Through Innovative Partnerships with PYXERA Global
Press Release

Come get a glimpse of how the world can be reimagined toward a much stronger future with your help.

CRB's SlateXpace™ Gives Cell and Gene Therapy Clients New Flexibility, Control Over Manufacturing Needs To Support Highly Complex Product Pipelines

CRB, a leader in the design and construction of biotech manufacturing facilities, creates SlateXpace – a multimodal facility solution that delivers unmatched industry speed, flexibility and adaptability for the advanced therapy market
Press Release

SAN DIEGO, Calif., Sept. 30, 2020 /3BL Media/ – Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time. Today, a pioneering multi-modality manufacturing solution addresses that challenge: SlateXpace™.

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S
Press Release

NEW BRUNSWICK, N.J., September 28, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development.

The Next Phase of Our COVID-19 Vaccine Development

by Alex Gorsky Chairman of the Board and Chief Executive Officer, Johnson & Johnson
Blog

It’s hard to believe that just six months have passed since our scientists identified Janssen’s lead COVID-19 vaccine candidate. We couldn’t have predicted all the changes that have happened since. Two things, however, have been constant: COVID-19 continues to be a devastating pandemic, and Johnson & Johnson has been working around the clock on a potential solution.

The Road to a Vaccine, Season 2, Ep. 7: Is It Really Safe for Schools to Be Open Right Now?

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.

Johnson & Johnson Consumer Health Commits $800 Million Through 2030 to Make Its Products More Sustainable for a Healthier Planet

Summary: 

As part of its new Healthy Lives Mission, the company's iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.

Article

As part of its new Healthy Lives Mission, the company's iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.

4 High-Tech Tools Johnson & Johnson Is Using to Get Products to You During the Pandemic

Article

When the COVID-19 pandemic first hit, everyday staples like toilet paper and paper towels were suddenly seemingly nowhere to be found. Over-the-counter products, like fever reducers and cough medicine, were in high demand—along with hand sanitizer, disinfectant sprays and cleaning wipes.

Building on Success Against COVID-19, Black & Veatch Launches Commercial Projects, Doubles IgniteX Funding

Registration being accepted for `Demo Day’ next month to showcase the innovations
Press Release

OVERLAND PARK, Kan., September 22, 2020 /3BL Media/ – With the goal of delivering solutions to safeguard communities against COVID-19, Black & Veatch’s IgniteX COVID-19 Response Accelerator has launched five projects of new-to-market technologies at commercial sites in the United States. Based on these early successes, Black & Veatch has announced it is doubling its funding goal for the program to $500,000.

Making Masks With a Higher IQ

Article

Breathing. Nothing comes more naturally to us. Here in 2020, there may be nothing more imperative to protecting both personal and global health than breathing through the new daily staple: a mask on every face.

Together with the support of VF’s product design and development teams, our JanSport® and Eagle Creek® brands have developed a range of new consumer mask choices that are not only fashionable, functional and compliant, but produced in an environmentally responsible manner.

A new product category

T‑Mobile Kicks‑Off 5G Research Challenge with University of Kansas to Transform the Future of Nursing

Summary: 

What’s the news: T-Mobile and students at the University of Kansas are teaming up this fall to research and develop 5G solutions that can revolutionize the future of nursing.

Why it matters: With the move to virtual education, creative new approaches using advanced technology to train healthcare workers and nursing students is needed now more than ever.

Who it’s for:  Anyone that relies on nurses for their health and well-being – so basically everyone.

Press Release

What’s the news: T-Mobile and students at the University of Kansas are teaming up this fall to research and develop 5G solutions that can revolutionize the future of nursing.

Why it matters: With the move to virtual education, creative new approaches using advanced technology to train healthcare workers and nursing students is needed now more than ever.

Who it’s for:  Anyone that relies on nurses for their health and well-being – so basically everyone.

Pages

Subscribe to Healthcare Innovation